Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000876099 | SCV001018623 | likely benign | Rubinstein-Taybi syndrome | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001593105 | SCV001824671 | likely benign | not provided | 2020-04-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501345 | SCV002809208 | likely benign | Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1 | 2022-02-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955737 | SCV004772329 | likely benign | CREBBP-related disorder | 2024-02-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |